한글목차

전 세계 세포 기반 어세이 시장 규모는 2024년 353억 달러에서 예측 기간 동안 연평균 9.8%의 CAGR로 2029년에는 563억 달러에 달할 것으로 예상됩니다.

소모품 부문은 2024년 199억 달러에서 예측 기간 동안 연평균 10.6%로 성장하여 2029년에는 329억 달러에 달할 것으로 예상됩니다. 장비 부문은 2024년 87억 달러에서 연평균 9.3%로 성장하여 2029년에는 135억 달러에 달할 것으로 예상됩니다.

세계의 세포 기반 어세이 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추정과 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 개요
• Drug Discovery
• 세포 기반 어세이의 중요성
• 세포 신호전달 경로
• 약물 작용 메커니즘
• 유전자 발현 제어
• 세포독성과 생존율
• 질환 모델
• 세포 기반 어세이 종류
• 세포 생존 어세이
• 세포 증식 어세이
• 세포독성 어세이
• 세포 기반 어세이 응용
• 의약품 발견과 개발
• 독성 연구
• 암 연구
• 감염증 연구
• 면역학과 염증
• 분자 경로 해석
• 재생의료와 조직공학
• 바이오마커 발견과 검증
• 정밀의료와 맞춤형 의료

제3장 시장 역학

• 개요
• 시장 성장 촉진요인
• 만성질환 발증률 상승
• 의약품 발견과 개발에 대한 수요 증가
• 맞춤형 의료에 대한 높은 수요
• 의약품 연구개발에 대한 투자 증가
• 시장 성장 억제요인
• 어세이 개발과 유지에 소요되는 고비용
• 기술적인 과제와 복잡성
• 시약이나 소모품의 짧은 보존 기간
• 시장 기회
• Drug Discovery의 응용 확대
• 진단과 바이오마커 발견 확대

제4장 신기술과 개발

• 개요
• 신기술
• CRISPR/Cas9 기술
• 하이컨텐트 스크리닝(HCS)과 이미징
• 데이터 분석의 AI와 머신러닝(ML)
• 특허 분석
• 특허 리뷰 : 주요 관할별

제5장 시장 세분화 분석

• 개요
• 세분화 내역
• 세포 기반 어세이 : 세계 시장
• 시장 분석 : 제품 유형별
• 소모품
• 기기
• 소프트웨어
• 서비스
• 시장 분석 : 용도별
• Drug Discovery
• 흡수, 분포, 대사, 배설(ADME)/독성
• 기초 연구
• 시장 분석 : 최종사용자별
• 바이오테크놀러지 및 제약 기업
• 학술연구기관
• CRO
• 지역적 내역
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 경쟁 구도
• 기업 순위

제7장 세포 기반 어세이 시장의 지속가능성 : ESG 관점

• 세포 기반 어세이 시장의 지속가능성
• 동물 실험
• 소형화와 자동화
• 그린 케미스트리와 친환경 재료
• 3D 세포배양과 조직 모델
• 폐기물 절감과 자원 최적화
• Drug Discovery 효율 향상
• ESG 리스크와 등급설정 : 데이터 이해
• BCC Research에 의한 견해

제8장 부록

• 조사 방법
• 정보 출처
• 약어
• 기업 개요
• AGILENT TECHNOLOGIES INC.
• BD
• BIOIVT
• BIO-RAD LABORATORIES INC.
• CELL BIOLABS INC.
• CELL BIOLOGICS INC.
• CHARLES RIVER LABORATORIES
• DANAHER CORP.
• FUJIFILM HOLDINGS CORP.
• GE HEALTHCARE
• LONZA
• MERCK KGAA
• PROMEGA CORP.
• REVVITY
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

The consumables market for cell-based assays is estimated to increase from $19.9 billion in 2024 to reach $32.9 billion by 2029, at a CAGR of 10.6% from 2024 through 2029.

The instruments market for cell-based assays is estimated to increase from $8.7 billion in 2024 to reach $13.5 billion by 2029, at a CAGR of 9.3% from 2024 through 2029.

Report Scope

The scope of this report on the global market for cell-based assay technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, application and end user. The report breaks down the cell-based assay market into four product categories: instruments, consumables, services, and software. It also segments the market by application, such as drug discovery; absorption, distribution, metabolism, and excretion (ADME)/toxicity testing; and basic research. The end users considered in the report include academic and research institutions, pharmaceutical and biotech companies, and clinical research organizations.

Geographically, the analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report also provides profiles of key market players and highlights industry trends, major products, mergers and acquisitions, and other partnerships expected to influence the future of the industry.

Report Includes

• 23 data tables and 48 additional tables
• Analyses of the trends in the global market for cell-based assays, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the market's current and future potential
• Estimates of the market for cell-based assays, revenue forecasts, and corresponding market share analysis by product, type/application, end user and geographic region
• Assessment of the current market, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
• Coverage of major issues involved in the R&D of more effective cell-based approaches for drug discovery
• Information on increasing investments in R&D activities, key technology issues, industry-specific challenges, major types of end users, and COVID-19 implications
• Discussion of ESG challenges and practices of the industry
• Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews
• Information on recent mergers and acquisitions, expansions, collaborations, investments, divestments and product launches
• Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Merck KGaA., Danaher Corp., Bio-Rad Laboratories Inc., and Charles River Laboratories.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Drug Discovery
• Importance of Cell-based Assays
• Cell Signaling Pathways
• Mechanisms of Drug Action
• Gene Expression Regulation
• Cytotoxicity and Viability
• Disease Modeling
• Types of Cell-based Assays
• Cell Viability Assays
• Cell Proliferation Assays
• Cytotoxicity Assays
• Application of Cell-based Assays
• Drug Discovery and Development
• Toxicology Studies
• Cancer Research
• Infectious Disease Research
• Immunology and Inflammation
• Molecular Pathway Analysis
• Regenerative Medicine and Tissue Engineering
• Biomarker Discovery and Validation
• Precision and Personalized Medicine

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Rising Incidence of Chronic Diseases
• Rising Demand for Drug Discovery and Development
• High Demand for Personalized Medicine
• Increasing Investment in Drug R&D
• Market Restraints
• High Cost of Assay Development and Maintenance
• Technical Challenges and Complexity
• Short Shelf-life of Reagents and Consumables
• Market Opportunities
• Expanding Applications in Drug Discovery
• Expansion in Diagnostics and Biomarker Discovery

Chapter 4 Emerging Technologies and Developments

• Overview
• Emerging Technologies
• CRISPR/Cas9 Technology
• High-content Screening (HCS) and Imaging
• AI and Machine Learning (ML) in Data Analysis
• Patent Analysis
• Patent Review, by Leading Jurisdiction

Chapter 5 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• Cell-based Assays: Global Markets
• Market Analysis by Product Type
• Consumables
• Instruments
• Software
• Services
• Market Analysis by Application
• Drug Discovery
• Absorption, Distribution, Metabolism, and Excretion (ADME)/Toxicity
• Basic Research
• Market Analysis by End User
• Biotechnology and Pharmaceutical Companies
• Academic and Research Institutes
• Contract Research Organizations
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Competitive Landscape
• Ranking of Companies in the Cell-based Assay Market

Chapter 7 Sustainability in Cell-based Assay Market: An ESG Perspective

• Sustainability in the Cell-based Assay Market
• Animal Testing
• Miniaturization and Automation
• Green Chemistry and Eco-friendly Materials
• 3D Cell Cultures and Tissue Models
• Waste Reduction and Optimization of Resources
• Improving Drug Discovery Efficiency
• ESG Risks and Ratings: Understanding the Data
• BCC Research Viewpoint

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BD
• BIOIVT
• BIO-RAD LABORATORIES INC.
• CELL BIOLABS INC.
• CELL BIOLOGICS INC.
• CHARLES RIVER LABORATORIES
• DANAHER CORP.
• FUJIFILM HOLDINGS CORP.
• GE HEALTHCARE
• LONZA
• MERCK KGAA
• PROMEGA CORP.
• REVVITY
• THERMO FISHER SCIENTIFIC INC.